Determination of Lipid Content and Stability in Lipid Nanoparticles Using Ultra High-performance Liquid Chromatography in Combination with a Corona Charged Aerosol Detector

Overview

Journal Electrophoresis

Specialty Chemistry

Date 2021 Nov 16

PMID 34784061

Citations 10

Authors

Caleb Kinsey

Tian Lu

Alyssa Deiss

Kim Vuolo

Lee Klein

Richard R Rustandi

John W Loughney

Affiliations

Soon will be listed here.

Abstract

For many years, lipid nanoparticles (LNPs) have been used as delivery vehicles for various payloads (especially various oligonucleotides and mRNA), finding numerous applications in drug and vaccine development. LNP stability and bilayer fluidity are determined by the identities and the amounts of the various lipids employed in the formulation and LNP efficacy is determined in large part by the lipid composition which usually contains a cationic lipid, a PEG-lipid conjugate, cholesterol, and a zwitterionic helper phospholipid. Analytical methods developed for LNP characterization must be able to determine not only the identity and content of each individual lipid component (i.e., the parent lipids), but also the associated impurities and degradants. In this work, we describe an efficient and sensitive reversed-phase chromatographic method with charged aerosol detection (CAD) suitable for this purpose. Sample preparation diluent and mobile phase pH conditions are critical and have been optimized for the lipids of interest. This method was validated for its linearity, accuracy, precision, and specificity for lipid analysis to support process and formulation development for new drugs and vaccines.

Citing Articles

Unleashing the potential of mRNA: Overcoming delivery challenges with nanoparticles.

Chen Q, Huo K, Ji S, Pang S, Sun T, Niu Y Bioeng Transl Med. 2025; 10(2):e10713.

PMID: 40060761 PMC: 11883111. DOI: 10.1002/btm2.10713.

Chemistry, manufacturing and controls strategies for using novel excipients in lipid nanoparticles.

OBrien Laramy M, Foley D, Pak R, Lewis J, McKinney E, Egan P Nat Nanotechnol. 2025; .

PMID: 39821140 DOI: 10.1038/s41565-024-01833-9.

Digitally Enabled Generic Analytical Framework Accelerating the Pace of Liquid Chromatography Method Development for Vaccine Adjuvant Formulations.

Hemida M, Barrientos R, Kinsey C, Kuster N, Bhavsar M, Beck A ACS Pharmacol Transl Sci. 2024; 7(10):3108-3118.

PMID: 39421659 PMC: 11480893. DOI: 10.1021/acsptsci.4c00306.

RP-CAD for Lipid Quantification: Systematic Method Development and Intensified LNP Process Characterization.

Beckert N, Dietrich A, Hubbuch J Pharmaceuticals (Basel). 2024; 17(9).

PMID: 39338379 PMC: 11435201. DOI: 10.3390/ph17091217.

Overcoming thermostability challenges in mRNA-lipid nanoparticle systems with piperidine-based ionizable lipids.

Hashiba K, Taguchi M, Sakamoto S, Otsu A, Maeda Y, Ebe H Commun Biol. 2024; 7(1):556.

PMID: 38730092 PMC: 11087515. DOI: 10.1038/s42003-024-06235-0.

References

Lian T, Ho R . Trends and developments in liposome drug delivery systems. J Pharm Sci. 2001; 90(6):667-80. DOI: 10.1002/jps.1023. View

Monslow M, Elbashir S, Sullivan N, Thiriot D, Ahl P, Smith J . Immunogenicity generated by mRNA vaccine encoding VZV gE antigen is comparable to adjuvanted subunit vaccine and better than live attenuated vaccine in nonhuman primates. Vaccine. 2020; 38(36):5793-5802. DOI: 10.1016/j.vaccine.2020.06.062. View

Swaminathan G, Thoryk E, Cox K, Meschino S, Dubey S, Vora K . A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens. Vaccine. 2015; 34(1):110-9. DOI: 10.1016/j.vaccine.2015.10.132. View

Grit M, Crommelin D . Chemical stability of liposomes: implications for their physical stability. Chem Phys Lipids. 1993; 64(1-3):3-18. DOI: 10.1016/0009-3084(93)90053-6. View

ENGEL L, Brooks P . Cholesterol is stable. Steroids. 1971; 17(5):531-9. DOI: 10.1016/s0039-128x(71)80155-1. View

Vehovec T, Obreza A . Review of operating principle and applications of the charged aerosol detector. J Chromatogr A. 2010; 1217(10):1549-56. DOI: 10.1016/j.chroma.2010.01.007. View

Krammer F . SARS-CoV-2 vaccines in development. Nature. 2020; 586(7830):516-527. DOI: 10.1038/s41586-020-2798-3. View

Mehnert W, Mader K . Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001; 47(2-3):165-96. DOI: 10.1016/s0169-409x(01)00105-3. View

Aliprantis A, Shaw C, Griffin P, Farinola N, Railkar R, Cao X . A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults. Hum Vaccin Immunother. 2020; 17(5):1248-1261. PMC: 8078688. DOI: 10.1080/21645515.2020.1829899. View

10.

Chesnut S, Salisbury J . The role of UHPLC in pharmaceutical development. J Sep Sci. 2007; 30(8):1183-90. DOI: 10.1002/jssc.200600505. View

11.

Abrams M, Koser M, Seitzer J, Williams S, DiPietro M, Wang W . Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: effect of dexamethasone co-treatment. Mol Ther. 2009; 18(1):171-80. PMC: 2839226. DOI: 10.1038/mt.2009.208. View

12.

Vervoort N, Daemen D, Torok G . Performance evaluation of evaporative light scattering detection and charged aerosol detection in reversed phase liquid chromatography. J Chromatogr A. 2007; 1189(1-2):92-100. DOI: 10.1016/j.chroma.2007.10.111. View

13.

Zhong Z, Ji Q, Zhang J . Analysis of cationic liposomes by reversed-phase HPLC with evaporative light-scattering detection. J Pharm Biomed Anal. 2009; 51(4):947-51. DOI: 10.1016/j.jpba.2009.10.001. View

14.

Sommer U, Herscovitz H, Welty F, Costello C . LC-MS-based method for the qualitative and quantitative analysis of complex lipid mixtures. J Lipid Res. 2006; 47(4):804-14. DOI: 10.1194/jlr.M500506-JLR200. View

15.

Radomska-Soukharev A . Stability of lipid excipients in solid lipid nanoparticles. Adv Drug Deliv Rev. 2007; 59(6):411-8. DOI: 10.1016/j.addr.2007.04.004. View

16.

McLaren D, Miller P, Lassman M, Castro-Perez J, Hubbard B, Roddy T . An ultraperformance liquid chromatography method for the normal-phase separation of lipids. Anal Biochem. 2011; 414(2):266-72. DOI: 10.1016/j.ab.2011.03.009. View

17.

Cullis P, Hope M . Lipid Nanoparticle Systems for Enabling Gene Therapies. Mol Ther. 2017; 25(7):1467-1475. PMC: 5498813. DOI: 10.1016/j.ymthe.2017.03.013. View

18.

Roos R, Lau-Cam C . General reversed-phase high-performance liquid chromatographic method for the separation of drugs using triethylamine as a competing base. J Chromatogr. 1986; 370(3):403-18. DOI: 10.1016/s0021-9673(00)94711-3. View

19.

Loughney J, Minsker K, Ha S, Rustandi R . Development of an imaged capillary isoelectric focusing method for characterizing the surface charge of mRNA lipid nanoparticle vaccines. Electrophoresis. 2019; 40(18-19):2602-2609. PMC: 6771570. DOI: 10.1002/elps.201900063. View

20.

Almeling S, Ilko D, Holzgrabe U . Charged aerosol detection in pharmaceutical analysis. J Pharm Biomed Anal. 2012; 69:50-63. DOI: 10.1016/j.jpba.2012.03.019. View